Arca Biopharma Coverage Initiated at Dawson James (ABIO)
Stock analysts at Dawson James assumed coverage on shares of Arca Biopharma (NASDAQ:ABIO) in a report issued on Wednesday, Analyst Ratings.Net reports. The firm set a “buy” rating and a $3.75 price target on the stock.
Arca Biopharma (NASDAQ:ABIO) opened at 1.51 on Wednesday. Arca Biopharma has a one year low of $1.13 and a one year high of $5.94. The stock’s 50-day moving average is $1.41 and its 200-day moving average is $1.71. The company’s market cap is $16.5 million.
ARCA biopharma, Inc (NASDAQ:ABIO) is a biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.